104 related articles for article (PubMed ID: 10201823)
1. Synthesis of bisquinolines and their in vitro ability to produce methemoglobin in canine hemolysate.
Srivastava S; Tewari S; Chauhan PM; Puri SK; Bhaduri AP; Pandey VC
Bioorg Med Chem Lett; 1999 Mar; 9(5):653-8. PubMed ID: 10201823
[TBL] [Abstract][Full Text] [Related]
2. A simple and rapid evaluation of methemoglobin toxicity of 8-aminoquinolines and related compounds.
Srivastava P; Singh S; Jain GK; Puri SK; Pandey VC
Ecotoxicol Environ Saf; 2000 Mar; 45(3):236-9. PubMed ID: 10702341
[TBL] [Abstract][Full Text] [Related]
3. An improved pharmacodynamic model for formation of methemoglobin by antimalarial drugs.
Fasanmade AA; Jusko WJ
Drug Metab Dispos; 1995 May; 23(5):573-6. PubMed ID: 7587933
[TBL] [Abstract][Full Text] [Related]
4. Methemoglobin reductase activity and in vitro sensitivity towards oxidant induced methemoglobinemia in swiss mice and beagle dogs erythrocytes.
Srivastava S; Alhomida AS; Siddiqi NJ; Puri SK; Pandey VC
Mol Cell Biochem; 2002 Mar; 232(1-2):81-5. PubMed ID: 12030383
[TBL] [Abstract][Full Text] [Related]
5. Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria.
Vennerstrom JL; Ellis WY; Ager AL; Andersen SL; Gerena L; Milhous WK
J Med Chem; 1992 May; 35(11):2129-34. PubMed ID: 1597862
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NADH-methemoglobin reductase by organic phosphates.
Matteson KJ; Taketa F
Biochim Biophys Acta; 1979 Nov; 571(1):112-9. PubMed ID: 497234
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and activity of some antimalarial bisquinolines.
Raynes K; Galatis D; Cowman AF; Tilley L; Deady LW
J Med Chem; 1995 Jan; 38(1):204-6. PubMed ID: 7837232
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.
Kondaparla S; Agarwal P; Srivastava K; Puri SK; Katti SB
Chem Biol Drug Des; 2017 Jun; 89(6):901-906. PubMed ID: 27896925
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antimalarial activity and inhibition of haem detoxification of novel bisquinolines.
Ayad F; Tilley L; Deady LW
Bioorg Med Chem Lett; 2001 Aug; 11(16):2075-7. PubMed ID: 11514142
[TBL] [Abstract][Full Text] [Related]
10. Bisquinolines. 2. Antimalarial N,N-bis(7-chloroquinolin-4-yl)heteroalkanediamines.
Vennerstrom JL; Ager AL; Dorn A; Andersen SL; Gerena L; Ridley RG; Milhous WK
J Med Chem; 1998 Oct; 41(22):4360-4. PubMed ID: 9784111
[TBL] [Abstract][Full Text] [Related]
11. The antimalarial drugs chloroquine and primaquine inhibit pyridoxal kinase, an essential enzyme for vitamin B6 production.
Kimura T; Shirakawa R; Yaoita N; Hayashi T; Nagano K; Horiuchi H
FEBS Lett; 2014 Oct; 588(20):3673-6. PubMed ID: 25157434
[TBL] [Abstract][Full Text] [Related]
12. Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation.
Raynes K; Foley M; Tilley L; Deady LW
Biochem Pharmacol; 1996 Aug; 52(4):551-9. PubMed ID: 8759027
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
14. Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to
Vieira JL; Ferreira MES; Ferreira MVD; Gomes MM
Am J Trop Med Hyg; 2017 May; 96(5):1171-1175. PubMed ID: 28440745
[TBL] [Abstract][Full Text] [Related]
15. Effects of hemolysate concentration, ionic strength and cytochrome b5 concentration on the rate of methemoglobin reduction in hemolysates of human erythrocytes.
Sannes LJ; Hultquist DE
Biochim Biophys Acta; 1978 Dec; 544(3):547-54. PubMed ID: 31928
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium chabaudi-infection of mice: effects of chloroquine and mefloquine. Inhibition of ornithine decarboxylase activity.
Königk E; Mirtsch S; Putfarken B; Abdel-Rasoul S
Tropenmed Parasitol; 1981 Jun; 32(2):73-6. PubMed ID: 6973226
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of certain hydroxy analogues of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes.
Allahyari R; Strother A; Fraser IM; Verbiscar AJ
J Med Chem; 1984 Mar; 27(3):407-10. PubMed ID: 6699888
[TBL] [Abstract][Full Text] [Related]
18. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.
Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K
J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927
[TBL] [Abstract][Full Text] [Related]
19. Methaemoglobin levels in soldiers receiving antimalarial drugs.
Sietsma A; Naughton MA; Harley JD
Med J Aust; 1971 Feb; 1(9):473-5. PubMed ID: 5552440
[No Abstract] [Full Text] [Related]
20. Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605).
Brueckner RP; Fleckenstein L
Pharm Res; 1991 Dec; 8(12):1505-10. PubMed ID: 1808614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
